3rd Quarter - Amendment

ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 18, 2018 — Replaced
3rd Quarter - Amendment (this page) Jan 18, 2019 — Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Short term limited duration plans in Medicare; Medicare Advantage improvements in Medicare; adult vaccines in Medicare Hospital Inpatient Prospective Payment Proposed Rule for FY2019; Lobbying Congress to weigh in with CMS on a coverage issue around transcatheter aortic valve replacement (TAVR) procedure.

LobbyistCovered position, as disclosed
ELLEN DUNBAR JENKINS —

Contacted: Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); SENATE

Budget/Appropriations BUD

Support increased funding for federal antimicrobial resistance initiatives in the President's budget. Oppose HHS proposed rule regarding short-term limited duration plans (STLDs) Oppose Right to Try bill (H.R.5247 & S.204) Support Appropriations for FY2019 for FDA, NIH, NIA, AHRQ Submitted comments to FDA re draft guidance for early Alzheimer's Disease: Developing Treatments Submitted comments to CMS re Medicare Advantage improvements Submitted comments to CMS re Medicare Program Hospital Inpatient Prospective Payment proposed rule for FY2019 in support of adult immunizations Submitted letter to Congress re H.J.Res 2 in opposition to the Balanced Budget Act

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern, Office of Representative Earl Perlmutter Extern, Office of Representative Christopher Carney
ELLEN DUNBAR JENKINS U.S. Senator Alan K. Simpson; U.S. House of Representatives Newt Gingrich

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5247 (115th), S. 204 (115th), H.J.Res. 2 (115th)

Health Issues HCR

Antimicrobial resistance funding and research; heart disease; appropriations for NIH/FDA/AHRQ/CDC; Short term limited duration plans (STLDP) in Medicare; FDA guidance on Alzheimer's Disease Research; adult vaccinations in Medicare; opposition to the Balanced Budget Act; opposition to S.204/H.R.5247 Right to Try legislation

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern, Office of Representative Earl Perlmutter Extern, Office of Representative Christopher Carney
ELLEN DUNBAR JENKINS Former Senator Alan Simpson; Rep. Newt Gingrich

Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); SENATE; Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: S. 204 (115th), H.R. 5247 (115th)

Medical/Disease Research/Clinical Labs MED

Increased research for antimicrobial resistance; FDA guidance on early Alzheimer's Disease research

LobbyistCovered position, as disclosed
RYNE C. CARNEY —
ELLEN DUNBAR JENKINS —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.